<DOC>
	<DOCNO>NCT00762047</DOCNO>
	<brief_summary>The purpose study evaluate new injectable bulking agent treatment fecal incontinence adult men woman . This study design assess safety , effectiveness performance Durasphere adult suffer fecal incontinence monitor clinical condition . The frequency severity fecal incontinence symptom measure use modify Cleveland Clinic Incontinence Score primary criterion success evaluate .</brief_summary>
	<brief_title>A Prospective , Multi-center , Randomized , Blinded Study Evaluate Durasphere FI Treatment Fecal Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>History fecal incontinence ; Incontinence episodes 14day period ; Eighteen year age old ; Abnormalities external sphincter great 10 mm ; Fibrosis tissue likely injection site ; Has condition could lead significant postoperative complication Rectal varix ; Cancer rectum colon , undergo active treatment ; Crohn 's disease ulcerative colitis ; Chronic diarrhea unmanageable drug and/or diet ; Rectal bleeding ; Pregnant within one year postpartum .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Fecal Incontinence</keyword>
</DOC>